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PplD is a de-N-acetylase of the cell wall linkage unit
of streptococcal rhamnopolysaccharides

1234567890():,;

Jeffrey S. Rush1, Prakash Parajuli 2, Alessandro Ruda 3, Jian Li1, Amol Arunrao Pohane 2,
Svetlana Zamakhaeva2, Mohammad M. Rahman2, Jennifer C. Chang 4, Artemis Gogos 4,
Cameron W. Kenner2, Gérard Lambeau 5, Michael J. Federle 4, Konstantin V. Korotkov 1,
Göran Widmalm 3 & Natalia Korotkova 1,2 ✉

The cell wall of the human bacterial pathogen Group A Streptococcus (GAS) consists of
peptidoglycan decorated with the Lanceﬁeld group A carbohydrate (GAC). GAC is a promising target for the development of GAS vaccines. In this study, employing chemical,
compositional, and NMR methods, we show that GAC is attached to peptidoglycan via
glucosamine 1-phosphate. This structural feature makes the GAC-peptidoglycan linkage
highly sensitive to cleavage by nitrous acid and resistant to mild acid conditions. Using this
characteristic of the GAS cell wall, we identify PplD as a protein required for deacetylation of
linkage N-acetylglucosamine (GlcNAc). X-ray structural analysis indicates that PplD performs
catalysis via a modiﬁed acid/base mechanism. Genetic surveys in silico together with
functional analysis indicate that PplD homologs deacetylate the polysaccharide linkage in
many streptococcal species. We further demonstrate that introduction of positive charges to
the cell wall by GlcNAc deacetylation protects GAS against host cationic antimicrobial
proteins.
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I

n Gram-positive bacteria, a cell wall outside the plasma membrane determines shape, ensures integrity, and protects the cell
from environmental stresses and host immune defense
mechanisms. In many streptococci, lactococci, and enterococci, the
cell wall consists of multiple layers of peptidoglycan covalently
modiﬁed with rhamnose (Rha)-containing polysaccharides1. These
essential polysaccharides are functional homologs of the canonical
poly(glycerol-phosphate) and poly(ribitol-phosphate) wall teichoic
acids (WTAs) expressed by Bacillus subtilis and Staphylococcus
aureus2, and non-canonical choline-containing WTAs produced
by the Streptococcus mitis group3.
Streptococcus pyogenes (Group A Streptococcus, GAS) is a
human pathogen of global signiﬁcance for which a vaccine is not
currently available4. The key antigenic surface polymer of GAS,
the Lanceﬁeld group A carbohydrate (GAC), is composed of a
repeating → 3)α-Rha(1 → 2)α-Rha(1 → disaccharide backbone
with N-acetyl-β-D-glucosamine (GlcNAc) side-chain modiﬁcations attached to the 3-position of the α-1,2-linked Rha5. GAC
has attracted signiﬁcant interest from the scientiﬁc and medical
communities as a vaccine candidate due to its uniform and
invariant expression in all GAS serotypes and the absence of the
constitutive component of GAC, Rha, in humans6–11. Furthermore, in proof-of-principle mouse immunization studies,
protein-conjugated GAC vaccines demonstrated efﬁcacy against
GAS strains6,7. To provide well-deﬁned GAC for immunological
studies and vaccine design, knowledge of the structure and biogenesis of GAC is essential9. The molecular mechanism of GAC
biosynthesis was proposed based on genetic and biochemical
studies of two genomic loci encoded by gacABCDEFGHIJKL and
gacO8,12–16. GAC biosynthesis is initiated on the inside of the
plasma membrane on a lipid carrier, undecaprenyl phosphate
(Und-P), by the action of the UDP-GlcNAc:Und-P GlcNAc-1phosphate transferase, GacO. After assembly of the polyrhamnose
backbone by the sequential activity of rhamnosyltransferases
GacB, GacC, GacG, and GacF, the nascent polysaccharide is then
translocated across the cell membrane via the ABC transporter
GacDE (Supplementary Fig. 1). Enzymatic machinery composed
of GacI, GacJ, GacK, and GacL catalyzes the addition of the
GlcNAc side-chains, which are then partially decorated with
glycerol phosphate (GroP) moieties by GacH15. Finally, the LytRCpsA-Psr (LCP) phosphotransferases transfer GAC from the
lipid carrier to peptidoglycan (Fig. 1a). This proposed assembly
mechanism is consistent with other isoprenol-mediated polysaccharide biosynthetic pathways in Gram-positive bacteria. The
enzymes involved in polyrhamnose biosynthesis and GroP
attachment are conserved and organized in similar gene clusters
in many streptococci suggesting signiﬁcant similarities in the
structures of streptococcal rhamnopolysaccharides1. However,
several details of this pathway are still speculative and require
further research. Importantly, the chemical structure of the
linkage of GAC to peptidoglycan has not been addressed.
In this study, we show that GAC is attached to peptidoglycan
via an unexpectedly stable linkage unit. This anomalous behavior
is due to the presence of a substantial portion of N-unsubstituted
glucosamine (GlcN) in the GAC-peptidoglycan linkage region.
We identify PplD, encoded by spy_0818 in the GAS 5005 genome,
as the enzyme responsible for deacetylation of GlcNAc in the
GAC linker unit. Furthermore, we reveal that deacetylation of the
cell wall GlcNAc residues protects GAS from host small cationic
antimicrobial proteins (AMPs).
Results
The GAC-peptidoglycan linkage is resistant to mild acid but
sensitive to nitrous acid deamination. GAC was presumed to be
covalently linked to peptidoglycan via a GlcNAc phosphodiester
2

to the 6-hydroxyl group of N-acetylmuramic acid (MurNAc).
This hypothesis is based on the observation that the biosynthetic
pathways of GAC, and the S. aureus and B. cereus WTAs share
initiating steps catalyzed by GacO homologs, providing the ﬁrst
sugar residue GlcNAc for the polysaccharide biosynthesis (Supplementary Fig. 1)2,8,13,17. In the ﬁnal steps of peptidoglycan
decoration with WTAs, the LCP phosphotransferases attach
GlcNAc 1-phosphate to peptidoglycan MurNAc residues forming
a GlcNAc phosphodiester bond to peptidoglycan18. The WTApeptidoglycan phosphodiester bond is acid labile19, and this
aspect of the S. aureus and B. subtilis cell walls has been used to
prepare undegraded, highly-enriched WTAs, freed of peptidoglycan remnants20,21. Accordingly, the GAC-peptidoglycan
linkage should also be sensitive to these conditions. We subjected
puriﬁed GAS cell wall and intact sacculi to mild acid conditions
(0.02 N HCl, 100 °C, 20 min), known to hydrolyze GlcNAc 1phosphate, and measured the release of water-soluble GAC.
Surprisingly, these well-established conditions released less than
25% of GAC from GAS (Fig. 1b, c). The resistance of GAC to
release by mild acid hydrolysis suggested the presence of an unacetylated amino sugar in the linkage region as has been reported
for Lactobacillus plantarum, which contains a GlcN 1-phosphatelinked WTA. A phosphodiester bond connecting the L. plantarum WTA to peptidoglycan is resistant to mild acid hydrolysis
unless ﬁrst chemically N-acetylated20. The chemical basis for the
extraordinary resistance of GlcN 1-phosphate to acid hydrolysis is
illustrated in Supplementary Fig. 2a, b. Hydrolysis of the glycosidic bond of GlcNAc 1-phosphate is facilitated by protonation of
the O1-oxygen and subsequent formation of a resonance stabilized oxonium ion intermediate (Supplementary Fig. 2a). However, this reaction is dramatically slowed during incubation of
GlcN 1-phosphate under these conditions, because the positively
charged GlcN-ammonium group destabilizes the adjacent oxonium ion intermediate (Supplementary Fig. 2b). To test the
possibility that a hexosamine residue, devoid of an N-acetyl
group, is present in the GAC-peptidoglycan linkage, puriﬁed GAS
cell wall or sacculi were ﬁrst chemically N-acetylated and then
subjected to mild acid hydrolysis. GAC was nearly quantitatively
released from peptidoglycan under these conditions, supporting
our hypothesis (Fig. 1b, c).
Sugars with primary amino groups, lacking N-acetyl groups,
undergo deamination by reaction with nitrous acid (HONO).
Deamination of polysaccharides containing GlcN residues results
in the formation of 2,5-anhydromannose and hydrolysis of the
glycosidic bond22, as illustrated in Supplementary Fig. 2c. This
selective cleavage has been utilized successfully to release the L.
plantarum WTA from peptidoglycan20. Nitrite is rapidly
protonated to form HONO in acidic conditions23. We observed
that incubation of isolated cell wall material and intact sacculi
with acidiﬁed nitrite released 70–80% of GAC in a water-soluble
form (Fig. 1b, d). In contrast, chemically N-acetylated GAS cell
wall or sacculi were resistant to this treatment (Fig. 1b, d). Taken
together, these results strongly suggest that GAC is attached to
peptidoglycan via a hexosamine 1-phosphate linkage.
The GAC-peptidoglycan linkage region contains GlcN and
GlcNAc. Our observation that HONO deamination cleaves only
70–80% of GAC from peptidoglycan, and that treatment with mild
acid released ~20–25% of GAC suggests that GAS produces two
classes of rhamnopolysaccharide composed of major and minor
fractions containing either hexosamine or N-acetylated hexosamine, respectively, in the linkage region. Importantly, mild acid
hydrolysis of chemically N-acetylated cell wall released GAC nearly
quantitatively (Fig. 1b), indicating that failure to achieve complete
release of GAC by these treatments was not due to incomplete
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hydrolysis of GAC from peptidoglycan or poor recovery of released
material. To verify this conclusion, we sequentially subjected previously deaminated cell walls to mild acid hydrolysis and measured
the release of soluble GAC (Supplementary Fig. 3). We observed
that the HONO-resistant rhamnopolysaccharide fraction was fully
released by the subsequent mild acid treatment. Furthermore,
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deamination of previously mild acid treated cell walls cleaves the
remaining ~80% of the GAC which is resistant to mild acid
hydrolysis (Supplementary Fig. 3).
To identify the hexosamine at the reducing end of the
acetylated and un-acetylated forms of GAC, the polysaccharide
was released from GAS cell wall by either deamination with
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Fig. 1 Analysis of GAC released from the GAS cell wall by chemical treatments. a Molecular model illustrating GAC covalently attached to peptidoglycan
via a phosphodiester bond. GAC contains a → 3)α-Rha(1 → 2)α-Rha(1 → repeating backbone. The β-GlcNAc side-chains are linked to the 3 position of the
α-1,2-linked Rha95,96. Phosphate groups in GAC are involved in the phosphodiester bond linking glycerol to the GlcNAc side-chain and the GAC reducing
terminal sugar residue to peptidoglycan15. b Release of GAC from GAS cell wall by mild acid hydrolysis or HONO deamination, before and after chemical Nacetylation. The treatment conditions are indicated by gray rectangles below the bar graph. c Release of GAC from GAS sacculi by mild acid hydrolysis,
before (left) and after (right) chemical N-acetylation. d Release of GAC from GAS sacculi by HONO deamination, before (left) and after (right) chemical Nacetylation. In b–d the concentration of GAC released from the sacculi was estimated by the modiﬁed anthrone assay described in “Methods” and
normalized to total GAC content in sacculi. Symbols and error bars represent the mean and S.D., respectively (n = 3 biologically independent replicates).
Data are mean values ± S.D., n = 3 biologically independent experiments. In b P values were calculated by one-way ANOVA with Tukey’s multiple
comparisons test. In c, d P values were calculated by two-way ANOVA with Tukey’s multiple comparisons test. Source data for b–d are provided as a
Source data ﬁle.

HONO (nitrous acid sensitive GAC, or GACNA) or mild acid
hydrolysis (mild acid sensitive GAC, or GACMA), and reduced
chemically with sodium borohydride. Sodium borohydride
reduces the aldehyde of 2,5-anhydromannose to form 2,5anhydromannitol and the hemiacetal of GlcNAc to form Nacetyl-D-glucosaminitol (GlcNAcitol). The reduced GACNA and
GACMA preparations were then fractionated by size-exclusion
chromatography (SEC) on BioGel P150. As conﬁrmed by the
composition analysis, both treatments released similar,
uniformly-sized polysaccharides eluting near the middle of the
column elution volume (Fig. 2a, b). When column fractions were
assayed by GC-MS as TMS-methyl glycosides, the GACNA and
GACMA preparations were found to contain Rha and GlcNAc as
the only component sugars detected (Fig. 2a, b, upper panels).
The reducing-end sugars were detected as alditol acetates by GCMS analysis. This method provides better detection of these
minor terminal sugars in the presence of high concentrations of
the polymer sugars, Rha and GlcNAc. We identiﬁed 2,5anhydromannitol in the GACNA preparations, and GlcNAcitol
in the GACMA preparations (Fig. 2a, b, bottom panels), co-eluting
with the peak of carbohydrate, as the only sugar alcohols in these
fractions, strongly suggesting that the extracted GAC material
contains GlcN and GlcNAc residues as the reducing moiety.
Notably, we observed a lower apparent recovery of 2,5anhydromannitol in the HONO-released fraction (Fig. 2b),
compared to the recovery of GlcNAcitol in the mild acid released
material (Fig. 2a). This result is expected because 2,5-anhydromannitol is not the sole product of deamination of
hexosamines22,24. In agreement, when we treated commercially
available GlcN 1-phosphate with HONO, only ~25% of the
expected 2,5-anhydromannitol was recovered (Supplementary
Fig. 4).
We have previously shown that GAS and Streptococcus mutans
produce rhamnopolysaccharides with variable GroP content, and
these forms can be separated by ion-exchange chromatography15,25.
Further experiments were performed to examine whether the GlcN
and GlcNAc linker residues are restricted to a speciﬁc ionic isoform
of GAC. Fractionation of GACNA and GACMA on DEAE
Toyopearl revealed that both polysaccharides contained a similar
array of ionic forms: a neutral glycan, not bound to the ionexchange column, and a strongly bound component (Fig. 2c).
Similar heterogeneity of GAC was previously observed when the
polysaccharide was cleaved from peptidoglycan by the peptidoglycan hydrolases15. As expected, the neutral glycan contains very low
phosphate content indicating that it has a low degree of GroP
modiﬁcation (Fig. 2c, d). The glycosyl composition of the pooled
GAC fractions revealed that the column-bound and unbound
fractions from both polysaccharide preparations contain similar
Rha/GlcNAc ratio (Fig. 2d). Furthermore, 2,5-anhydromannitol
was detected in both the column-bound and unbound fractions of
the GACNA preparations, and GlcNAcitol in both the columnbound and unbound fractions of the GACMA preparations (Fig. 2d).
4

These observations provide evidence that the GlcN and GlcNAc
linker isoforms are not speciﬁcally linked to the presence or absence
of GroP in GAC and that the only apparent difference in the two
populations of GAC is the acetylation status of the linkage
GlcN unit.
Chemical structure of the GAC-peptidoglycan linkage region.
To elucidate the exact chemical structure of the linkage region,
GAC liberated from peptidoglycan by the peptidoglycan hydrolases, PlyC and mutanolysin15, was subjected to NMR analysis. As
expected from our previous study15, when GAC material was
analyzed by 1H,13C-HSQC NMR, the GAC trisaccharide repeating
units, → 3)-α-L-Rhap-(1 → 2)[β-D-GlcpNAc-(1 → 3)]-α-LRhap-(1 → , were observed at highest level of intensity. The
polysaccharide decorated by sn-Gro-1-phosphate groups as substituents at O6 of the side-chain D-GlcpNAc residues were
identiﬁed at the second intensity level of NMR spectra15. To
unravel how GAC is linked to peptidoglycan, the analysis was
performed at the third level of intensity in the NMR spectra. In
the 31P NMR spectrum of GAC, a resonance was observed at
−1.35 ppm, having a chemical shift characteristic of a
phosphodiester26. From 1H,31P-Hetero-TOCSY experiments27
correlations may be detected from the 31P nucleus to protons of
adjacent residues and in the spectrum with a mixing time of
50 ms cross-peaks were observed to protons of a methylene
group, δH 4.10 and 4.19, identiﬁed in a multiplicity-edited
1H,13C-HSQC spectrum (δ
C6 64.3) (Fig. 3); these correlations
were conﬁrmed via 1H,31P-HMBC experiments. A longer mixing
time of 80 ms in the 1H,31P-HMBC experiment and analysis of
1H,1H-TOCSY spectra for which mixing times up to 120 ms were
used in conjunction with 1H,13C-HSQC, 1H,13C-HSQC-TOCSY
and 2D 1H,1H-NOESYspectra, complemented by NMR chemical
shift predictions made by the CASPER program,28 facilitated
identiﬁcation of a hexopyranoside (δC1 102.4) spin-system having
the gluco-conﬁguration. Importantly, in the 1H,13C-HMBC
spectrum a correlation was observed between δHα 4.36 of a lactyl group and δC3 80.2 of the hexopyranoside residue and in a
1H,1H-NOESY spectrum connectivity between entities was further substantiated by a cross-peak at δHα 4.36/δH3 3.63 thereby
identifying the sugar having δC4 75.7 and 1JC1,H1 167 Hz as a βMurNAc residue being part of a peptidoglycan chain (Supplementary Table 1). The 13C NMR resonance assigned to C5 of the
MurNAc residue showed 3JC5,P 7.6 Hz, fully consistent with a
phosphodiester 6-O-substitution29. The spectral data of nuclei in
the hexopyranose ring are consistent with previously reported
NMR chemical shift assignments of an oligomeric form of peptidoglycan structures30.
The 1H,31P-Hetero-TOCSY spectra employing a mixing time
of 50 ms also showed correlations from 31P to a proton at δH1
5.54 and with a longer mixing time of 80 ms a cross-peak was
identiﬁed at δH2 2.89 (Fig. 3); these correlations were conﬁrmed
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Fig. 2 Glycosyl composition analysis of GAC released from cell wall by the chemical treatments and puriﬁed by size-exclusion and ion-exchange
chromatography. a Size-exclusion chromatography of GAC released from GAS cell wall by mild acid hydrolysis or b deamination with HONO. Upper and
lower panels show the composition of the BioGel P150 fractions of the individual GAC preparations. Prior to the chromatography, the extracted GAC
material was reduced chemically with sodium borohydride. Fractions were analyzed for phosphate content by malachite green assay following digestion
with perchloric acid. Rha and GlcNAc contents were measured by GC-MS as TMS-methyl-glycosides. GlcNAcitol and 2,5-anhydromannitol contents were
estimated by GC-MS as alditol acetates. The chromatographic proﬁles are representative of more than three separate experiments. c Ion-exchange
chromatography of GAC released from the GAS cell wall by mild acid (upper panel) and HONO (lower panel). Fractions containing the GAC material from
(a, b) were pooled, concentrated, desalted by spin column, loaded onto DEAE-Toyopearl and eluted with a NaCl gradient (0–0.5 M). Fractions were
analyzed for total sugar content by anthrone assay and total phosphate content by malachite green assay following perchloric acid digestion. The
experiments were performed at least three times and yielded the same results. Data from one representative experiment are shown. d Glycosyl
composition analysis of the GAC material puriﬁed by ion-exchange chromatography. The GAC material released by either deamination with HONO
(GACNA) or mild acid hydrolysis (GACMA) was analyzed as shown in (c). Fractions unbound (ﬂow-through) and bound (eluted with a NaCl gradient) to
the DEAE column were pooled, concentrated, desalted by spin column and analyzed by GC-MS to determine the Rha, GlcNAc, 2,5-anhydromannitol and
GlcNAcitol concentrations as described above. Malachite green assay was used to assay the phosphate concentration. The concentrations of GlcNAc, 2,5anhydromannitol, GlcNAcitol and phosphate are expressed as moles per 30 moles of Rha. Columns and error bars represent the mean and S.D.,
respectively (n = 4 biologically independent replicates). Source data are provided as a Source data ﬁle.

in a 1H,31P-HMBC spectrum. The combined analysis of
1H,1H-TOCSY and 1H,13C-HSQC spectra indicated that the
spin-system originates from a hexopyranoside residue (δC1 96.5)
having the gluco-conﬁguration with an α-anomeric conﬁguration
(1JC1,H1 177 Hz) as part of a phosphodiester linkage31,32. The 13C
NMR chemical shift δC2 56.0 is indicative of a nitrogen-carrying

carbon suggesting that this residue is the primer of the GAC16.
However, the 1H NMR chemical shift δH2 2.89 at pD ~8 is
conspicuously low and was pD-dependent, which supports that
the D-GlcN residue is devoid of an N-acetyl group33–35.
Furthermore, a β-L-Rhap residue was identiﬁed by 1JC1,H1
163 Hz and intra-residue cross-peaks in a 1H,1H-NOESY
spectrum from H1 to H2, H3, and H5. The 13C NMR chemical
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Fig. 3 Chemical structure of the GAC-peptidoglycan linkage region determined by NMR analysis. Representative structure of the linkage region of GAC
anchored to the peptidoglycan layer (top). 1H,31P-HMBC NMR spectrum (a) with a 90 ms delay for the evolution of long-range J couplings shows the key
correlation between proton H1 (b) and H2 (d) of GlcN, and the two protons in position 6 of MurNAc (c) to a unique 31P signal at −1.35 ppm, characteristic
of a phosphodiester linkage between the two residues. b–d Show the corresponding signals in the multiplicity-edited 1H,13C-HSQC NMR spectrum. The two
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shift of C3 at δC3 81.4 in the β-L-Rhap residue (Supplementary
Table 1) is higher by 7.6 ppm compared to that of the
monosaccharide36, suggesting that it is substituted by a sugar
residue at O337. The priming D-GlcN residue is substituted at O4
by the β-L-Rhap residue as seen from a 1H,13C-HMBC correlation
δH1 4.89/δC4 77.7 and in a 1H,1H-NOESY spectrum with a crosspeak at δH1 4.89/δH4 3.69, consistent with a β-L-Rhap-(1 → 4)-αD-GlcpN disaccharide, derived from transfer of L-Rha from TDPβ-L-Rha onto the acceptor GlcNAc-PP-Und catalyzed by GacB16
(Supplementary Fig. 1). Taken together, the results from the
NMR analysis show that GAC is attached by its primer D-GlcN
via a phosphodiester linkage to MurNAc of the peptidoglycan.
The newly synthesized cell wall is decorated with GlcNAc 1phosphate-linked GAC. In Gram-positive bacteria, the cell wall
polysaccharides conceal peptidoglycan from molecular interactions with proteins25,38. We reasoned that since the chemical
treatments of GAS sacculi cleave a speciﬁc form of GAC possessing either the GlcN or GlcNAc residues in the GACpeptidoglycan linkage, these treatments might reveal surface
peptidoglycan regions expressing the pertinent modiﬁcation by
following peptidoglycan-speciﬁc protein binding. Thus, to examine the cellular localization of these speciﬁc GAC forms, we
generated a ﬂuorescent molecular tool with tight binding to
peptidoglycan. We constructed a protein fusion, GFP-AtlAEfs, in
which the C-terminal cell wall-binding domain of the Enterococcus faecalis major cell division autolysin AtlA39,40 is fused at
the N-terminus with a green ﬂuorescent protein (GFP) (Supplementary Fig. 5). This cell wall-binding domain consists of six
LysM repeats (Pfam PF01476) that recognize peptidoglycan41. The
protein fusion was added exogenously to the GAS sacculi subjected to either no treatment, mild acid hydrolysis, or deamination. Fluorescence microscopy imaging revealed that the protein
fusion did not associate with the majority of untreated sacculi
(Fig. 4 and Supplementary Table 2). In contrast, the sacculi treated
with HONO demonstrated uniform distribution of GFP-AtlAEfs
over the cell surface (Fig. 4). Interestingly, the majority of sacculi
subjected to mild acid hydrolysis were stained by GFP-AtlAEfs in
the regions of active cell division: septal regions and newly formed
6

Treatment

Untreated

Mild acid

HONO

GFP-AtlAEfs
1 μm

DIC

Merge

Fig. 4 Binding of GFP-AtlAEfs to GAS sacculi. Intact sacculi (untreated),
sacculi subjected to mild acid hydrolysis (mild acid), or deamination with
HONO (HONO) were incubated with GFP-AtlAEfs, and examined by
ﬂuorescence microscopy (GFP-AtlAEfs, top panels) and differential
interference contrast (DIC, middle panels). An overlay of ﬂuorescence and
DIC (merge) is shown in the bottom panels. The experiments were
performed independently three times and yielded the same results.
Representative image from one experiment is shown. Scale bar is 1 µm.

poles (Fig. 4 and Supplementary Table 2). This observation indicates that i) the chemical treatments do not lead to degradation of
the peptidoglycan sacculi; and ii) the regions of active cell division
contain the GlcNAc 1-phosphate-linked GAC. These zones correspond to the newly synthesized cell wall.
PplD deacetylates the GAC-peptidoglycan linkage region. Our
observation that a substantial fraction of the GAC-peptidoglycan
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linkage region carries a GlcN residue suggests enzymatic deacetylation of GlcNAc as an undescribed step in GAC biosynthesis.
The GAS genome encodes two proteins, PgdA and Pdi, annotated
as putative GlcNAc deacetylases. PgdA is a homolog of the
peptidoglycan GlcNAc N-deacetylase from Streptococcus
pneumoniae42. Pdi was originally identiﬁed in the ﬁsh pathogen
Streptococcus iniae43. While the function of this protein has not
been described, it was named Pdi for polysaccharide deacetylase
of S. iniae. We renamed this protein to PplD (polysaccharidepeptidoglycan linkage deacetylase) for the reasons provided
below. To examine the functions of PplD and PgdA in deacetylation of the GAC linker region, we generated pplD and pgdA
single deletion mutants and the double deletion mutant in a GAS
NZ131 strain, creating GASΔpplD, GASΔpgdA, and
GASΔpplDΔpgdA, respectively. Since the chemical treatments
produced similar results with the GAS cell wall and sacculi
(Fig. 1b–d), for convenience we used the sacculi of the constructed strains to test the sensitivity of the phosphodiester
linkage to mild acid and HONO treatment. Mild acid hydrolysis
liberated the polysaccharide almost quantitatively from the
GASΔpplD and GASΔpplDΔpgdA sacculi (Fig. 1c). Conversely,
the sacculi of these mutants were almost completely resistant to
deaminative cleavage with HONO (Fig. 1d). Moreover, chemical
N-acetylation of the GASΔpplD and GASΔpplDΔpgdA sacculi
prior to the treatments with either mild acid or HONO did not
signiﬁcantly affect the release of GAC (Fig. 1c, d). In contrast, the
GASΔpgdA sacculi behaved in these assays like the WT control
(Fig. 1c, d). These data indicate that PplD is required for deacetylation of the GAC-peptidoglycan linker region.
PplD structure. PplD is predicted to contain an N-terminal
transmembrane helix and an extracellular catalytic domain
(ePplD) connected by a linker region. To facilitate the functional
analysis of PplD, we solved the crystal structure of ePplD (residues 94–320) to 1.78 Å resolution (Supplementary Table 3).
There were two molecules in the asymmetric unit that are very
similar to each other with a r.m.s.d. of 0.3 Å over 226 aligned Cα
atoms. Analysis of the crystal contacts revealed that the dimer
interface is the largest with 632 Å2 buried surface area that scored
below the stable complex formation criteria44. In addition, ePplD
behaves as a monomer in solution according to SEC. The structure of ePplD revealed a (β/α)7-barrel fold that is characteristic of
carbohydrate esterases of the CE4 family (Fig. 5a). The analysis of
the putative active site revealed the presence of a metal ion, which
we identiﬁed as Zn2+ based on analysis of anomalous difference
maps and temperature factors of the ion and coordinating atoms.
The Zn2+ ion is coordinated by the side chains of residues D168,
H223, and H227 (Fig. 5b). This coordination pattern of the D-HH residues is common for the metal coordination in CE4 family
members. An additional electron density observed next to the
Zn2+ ion was assigned as acetate, one of the products of the
deacetylation reaction. The compound makes a bi-dentate contact
with the Zn2+ ion. Altogether, the side chains of D168, H223, and
H227, acetate and a water molecule complete an octahedral
coordination of the Zn2+ ion (Fig. 5b). One of the oxygen atoms
of acetate makes a hydrogen bond with the backbone amide of
S264, an oxyanion hole, while another oxygen atom of acetate
forms a hydrogen bond with catalytic residue H105. A semiburied D167, which is likely involved in coordination of a catalytic water molecule, makes a bi-dentate salt bridge with R302
and an additional hydrogen bond with N191. Altogether, the
structural features of ePplD are consistent with the deacetylase
function of this enzyme.
The structural comparison of PplD with the available protein
structures shows that this enzyme is more distantly related to S.

ARTICLE

pneumoniae PgdA45, but similar to the exopolysaccharide polyN-acetylglucosamine (PNAG) deacetylases PgaB and IcaB
produced by Escherichia coli and Ammonifex degensii, respectively (Supplementary Table 4)46,47. The core of the catalytic
domains of PplD and PgdA is similar with a r.m.s.d. of 2.4 Å over
140 Cα atoms. However, the N- and C-termini are swapped and
located on the opposite ends of β/α barrel (Supplementary Fig. 6).
Moreover, in comparison to canonical members of the CE4
protein family, PplD displays differences in the MT1-MT5
sequence motifs. While, the MT1, MT2, and MT5 motifs
containing the catalytic residues and the residues coordinating
Zn2+ ion are conserved in PplD and PgdA (Supplementary
Fig. 6), PplD lacks the MT4 motif that carries an aspartic acid
residue involved in activation of the catalytic histidine (H105 in
PplD). Additionally, the MT3 motif of PplD lacks an arginine
residue that coordinates a catalytic aspartic acid residue (D167 in
PplD). Instead, D167 is coordinated by R302 located at a different
position in the sequence. These sequence deviations from
canonical CE4 hydrolases are also present in E. coli PgaB and
A. degensii IcaB.
To functionally assess the requirement of the presumed
catalytic residues of PplD, we complemented GASΔpplD and
GASΔpplDΔpgdA with WT pplD expressed on a plasmid
creating the GASΔpplD:ppplD and GASΔpplDΔpgdA:ppplD
strains, and GASΔpplD with catalytically inactive versions of
pplD in which the active site residues H105 and D167, were
replaced by alanine and asparagine, respectively, creating
GASΔpplD:ppplD-H105A,
GASΔpplD:ppplD-D167N,
and
GASΔpplD:ppplD-H105A/D167N. Complementation of the
mutants by expression of the WT pplD completely restored
the phenotype of the mutants (Figs. 1c, d, 5c). Importantly, in
GASΔpplD:ppplD and GASΔpplDΔpgdA:ppplD, the phosphodiester GAC-peptidoglycan bond was signiﬁcantly more
sensitive to deaminative cleavage by HONO than in the WT
(Figs. 1d and 5c). This result indicates that the plasmid
expression of PplD in GAS provided the cells with fully
deacetylated GAC linker region. In contrast, the
and
GASΔpplD:ppplD-H105A,
GASΔpplD:ppplD-D167N,
GASΔpplD:ppplD-H105A/D167N mutants behaved similarly
to GASΔpplD (Fig. 5c). Thus, based on the functional
requirement of H105 and D167 for catalysis and the structural
features of the active site, we propose that PplD functions via
an alternative enzymatic mechanism similar to A. degensii
IcaB47. In this mechanism, the hydrolysis of the GlcNAc
moiety would occur via a water molecule coordinated by Zn2+
ion and D167 (Fig. 5d). The nucleophilic attack on the N-acetyl
group of the GlcNAc residue would be initiated by deprotonation of the catalytic water molecule by H105. The resulting
tetrahedral oxyanion intermediate would be coordinated by the
Zn2+ ion and the backbone amide of S264 acting as an
oxyanion hole. The protonation of the nitrogen of the
intermediate by H105 in the histidinium form would lead to
hydrolysis and generation of the GlcN moiety and a free
acetate. In this mechanism, H105 would serve as a bifunctional
catalytic base/acid of the reaction.
Modulation of the cell wall net charge by PplD, PgdA, and
GacH affects resistance to AMPs. In a number of bacteria, PgdA
protects bacteria from host AMP, lysozyme, by deacetylating the
peptidoglycan GlcNAc residues42,48–50. Lysozyme catalyzes the
breakdown of β-(1,4) linkages between the MurNAc and GlcNAc
saccharides leading to peptidoglycan hydrolysis and bacterial
lysis51. In addition to N-acetylmuramidase activity, lysozyme kills
bacteria by a non-enzymatic mechanism52. This mechanism is
similar to killing by small cationic peptides53, and is attributed to
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Fig. 5 PplD deacetylates GlcNAc in the GAC-peptidoglycan linkage region. a Predicted topology of PplD showing a transmembrane helix and structure of
extracellular domain with the enzymatic active site is depicted on left panel. Right panel depicts the structure of ePplD viewing at the active site with the
Zn2+ ion shown as a magenta sphere. b A close-up view of the active site PplD structure in complex with acetate. c The sacculi puriﬁed from GAS WT,
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lysozyme crossing the cell wall and binding to negatively charged
bacterial membranes thus leading to membrane permeabilization.
Deacetylation of GlcNAc in peptidoglycan by PgdA directly alters
lysozyme binding to its substrate negatively affecting lysozymemediated degradation of peptidoglycan. Interestingly, in S. iniae,
the PplD homolog also confers resistance to lysozyme43. Hence,
to understand the role of cell wall deacetylation in protection of
GAS against lysozyme, ﬁrst, we assessed muramidase-dependent
lysis of the WT GAS, GASΔpplD, GASΔpgdA, and
GASΔpplDΔpgdA cells treated with lysozyme. When GAS strains
were incubated with 1 mg/ml lysozyme for 18 hours, no
lysozyme-dependent decrease in turbidity was observed consistent with the established high resistance of GAS to lysozyme. In
contrast, incubation of GAS strains with an alternative highly
efﬁcient N-acetylmuramidase, mutanolysin, produced a substantial drop in turbidity compared to control (Supplementary
Fig. 7). Since the sensitivity of GAS to lysozyme appeared to be
below the limits of detection detected by turbidity analysis, cell
wall degradation was estimated with a more sensitive assay using
dot-blot analysis for the water-soluble form of GAC released from
the bacteria during digestion (Supplementary Fig. 8a). Lysozyme
produced a very weak solubilization of GAC from WT GAS and
8

GASΔpplD cells, and more pronounced release of GAC from
GASΔpgdA and GASΔpplDΔpgdA cells (Supplementary Fig. 8b).
Furthermore, lysozyme released GAC from GASΔpplDΔpgdA
more efﬁciently, than from GASΔpgdA (Supplementary Fig. 8b).
Altogether, these data indicate that lytic degradation of the GAS
cell wall by lysozyme is minor due to the presence of GlcN in
peptidoglycan as the result of PgdA catalytic activity. However,
when PgdA is absent, deacetylation of the GAC linker region by
PplD can be detected as a factor conferring protection against
lysozyme-mediated lysis.
We previously reported that in comparison to the parental
strain, the GroP-deﬁcient mutant of GAS, GASΔgacH, is
signiﬁcantly more resistant to a highly cationic enzyme human
group IIA secreted phospholipase A2 (hGIIA sPLA2 hereafter
hGIIA)15. This phenotype is likely due to either decreased
binding of hGIIA to the cell surface or reduced permeability of
the cell wall to hGIIA. Since deacetylation of GlcNAc residues
increases the cell wall net positive charge, it might lead to
neutralization of negative charges conferred by GroP moieties
and as a result, affect the translocation of cationic AMPs across
the cell wall. To understand how modulation of the cell wall net
charge by deacetylation of GlcNAc residues alters susceptibility of
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GAS to cationic AMPs, we analyzed the resistance of WT GAS,
GASΔpplD, GASΔpgdA, GASΔpplDΔpgdA to the antimicrobial
action of hGIIA, lysozyme, or histone mixture (Fig. 6a–c and
Supplementary Fig. 8c). We observed that deletion of either pplD
or pgdA, or both genes, yielded strains with enhanced susceptibility to hGIIA (Fig. 6a). In contrast, deletion of pplD did not
affect susceptibility of bacteria to lysozyme (Fig. 6b and
Supplementary Fig. 8c) or a histone mixture (Fig. 6c). However,
sensitivity to killing by these AMPs was signiﬁcantly increased in
GASΔpgdA and GASΔpplDΔpgdA, with a more pronounced
effect observed in GASΔpplDΔpgdA. Moreover, the expression of
WT PplD in GASΔpplD and GASΔpplDΔpgdA signiﬁcantly
increased the resistance of the parental strains to the AMPs,
especially for hGIIA (Fig. 6a–c and Supplementary Fig. 8c). This
observation correlates with the conclusion that the level of
deacetylation of the GAC-peptidoglycan linkage region in the

complemented strains is higher than in the WT strain, and
indicates that both PgdA and PplD enhance resistance of GAS to
the tested AMPs.
Finally, we examined susceptibility of the GroP-deﬁcient
mutant, GASΔgacH, and its complemented strain, GASΔgacH:pgacH, to the antimicrobial action of lysozyme or histones to
conﬁrm that the mechanisms of lysozyme and histone killing of
GAS are charge-dependent. Deletion of gacH rendered GAS more
resistant to lysozyme and histones, and the phenotype was
reversed by complementation of GASΔgacH with WT gacH
(Fig. 7a, b). Collectively, our results are consistent with a model in
which the addition of positive residues by deacetylation of
GlcNAc in peptidoglycan and the GAC linkage region counteracts the cell wall net negative charge provided by GroP moieties
resulting in reduced translocation of cationic AMPs across the
cell wall (Fig. 7c).
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PplD homologs deacetylate respective rhamnopolysaccharides
in streptococci. To understand whether deacetylation of the
polysaccharide-peptidoglycan linkage region is widespread in
bacteria, we examined the distribution of the PplD family of
proteins throughout the bacterial kingdom. PplD homologs were
predominantly identiﬁed in the genomes of streptococcal species
(Supplementary Fig. 9). Interestingly, members of the S. mitis
group, that express choline-containing WTAs, and not Rhacontaining polysaccharides, possess only the PgdA homolog,
supporting the conclusion that PplD is only active on rhamnopolysaccharides. We also observed that genes encoding pplD
homologs in a number of streptococcal strains contain a frame
shift mutation and thus are likely non-functional. Hence, to
investigate the function of PplD in streptococcal species, we
selected for analysis the following strains: Streptococcus agalactiae
(Group B Streptococcus, GBS) A909, S. mutans Xc, and Streptococcus equi subsp. equi CF32 in which pplD is an intact gene,
and GBS COH1 and Streptococcus thermophilus LMG 18311 in
which the pplD homologs have a frame shift mutation (Supplementary Fig. 10). Additionally, we deleted the pplD homologs in
S. mutans Xc and GBS A909 strains creating the SMUΔpplD and
GBSΔpplD strains. In agreement with the function of PplD in
deacetylation of the polysaccharide-peptidoglycan linker, the
rhamnopolysaccharides were liberated from the cell walls by
HONO in the strains with the intact pplD (Fig. 8a, b). In contrast,
this treatment did not cleave the polysaccharides from the strains
carrying the inactivated pplD. However, these polysaccharides
were released by mild acid hydrolysis (Fig. 8a, b). Furthermore,
expression of the GAS WT PplD but not the catalytically inactive
versions of PplD, PplD-D167N, and PplD-H105A/D167N,
restored the phenotype of SMUΔpplD (Fig. 8a). Taken together,
the results support the conclusion that in the large group of
streptococci expressing the Rha-containing polysaccharides, the
polysaccharide-peptidoglycan linkage region is deacetylated by
PplD homologs suggesting that PplD recognizes for catalysis the
polyrhamnose linker region sugars that are conserved in many
streptococci1,16.
Discussion
Currently, no licensed vaccine exists for GAS which is a leading
cause of morbidity and mortality worldwide. Glycoconjugate
vaccines obtained by covalent linkage of bacterial polysaccharides
to carrier proteins have been proven highly successful in the
prevention of a number of infectious diseases54. The major
component of GAS cell wall, GAC, is an important determinant
of viability and virulence, and is a promising target for the
development of vaccines to treat GAS infections. One of the
obstacles to the GAC-based vaccine development is the lack of
efﬁcient and structurally accurate methods of GAC conjugation
to protein carriers9, primarily as a result of misperceptions of the
chemical nature of the GAC-peptidoglycan linkage unit. A consequence of this incomprehension is that previous methods for
preparation of GAC have either been notably inefﬁcient or relied
on harsh chemical treatments for polysaccharide cleavage and the
insertion of reactive chemical groups required for coupling
reactions to carrier proteins6–11. In this report, using NMR studies together with chemical degradation and glycosyl composition
analysis, we demonstrate that a signiﬁcant fraction of GAC
contains GlcN 1-phosphate in the peptidoglycan linkage unit.
This previously unrecognized structural feature of the GAC
introduces a positive charge at the site of attachment to peptidoglycan, rendering the GAC-peptidoglycan linkage resistant to
cleavage by mild acid, but sensitive to cleavage by HONO.
Importantly, our study reveals that mild acid hydrolysis, following chemical N-acetylation produces nearly quantitative release of
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Fig. 8 Analysis of PplD-mediated deacetylation in streptococcal species.
a Release of SCC from the sacculi puriﬁed from S. mutans strains by mild
acid hydrolysis (left) or deamination with HONO (right). b Release of the
Rha-containing polysaccharides from the cell wall puriﬁed from GBS, S. equi
and S. thermophilus strains by mild acid hydrolysis (left) or deamination with
HONO (right). The concentration of polysaccharide released from the
sacculi or cell wall was estimated by the modiﬁed anthrone assay and
normalized to total content of polysaccharide in the starting material.
Symbols and error bars represent the mean and S.D., respectively (n = 3
biologically independent replicates). P values were calculated by two-way
ANOVA with Tukey’s multiple comparisons test. Source data are provided
as a Source data ﬁle.

GAC with a reducing end sugar (GlcNAc) which is suitable for
efﬁcient coupling to free amino groups of target proteins by
reductive amination. GAC released by this gentle method provides a much more appropriate substrate for preparation of
immunogens because all labile substituents are preserved. Thus,
this improved insight into the chemical structure of the GACpeptidoglycan linkage and the products generated by chemical
treatments will guide optimization of conjugation processes with
GAC resulting in production of well-deﬁned homogeneous glycoconjugate vaccine.
Previously, similar sensitivity to cleavage by mild acid and
HONO was only observed for the WTA of L. plantarum AHU
141320. We extended the analysis of sensitivity of polysaccharide
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cleavage by these treatments to other streptococcal species
revealing the presence of GlcN residues in the Rha-containing
polysaccharide linkers of GBS, S. mutans and S. equi. In bacteria,
enzymatic deacetylation of GlcNAc residues in peptidoglycan,
chitin and the exopolysaccharide PNAG is carried out by CE4
family enzymes42,47,55,56. GAS, S. mutans, S. equi, and GBS
genomes encode two CE4 enzymes, the peptidoglycan deacetylase
PgdA and the PplD protein. Using sensitivity to polysaccharide
cleavage by mild acid and HONO, we demonstrate that PplD is
critical for deacetylation of GlcNAc in the linkage unit of the Rhacontaining polysaccharides of GAS, GBS and S. mutans. The
structural analysis of GAS PplD together with the functional
analysis of the site-directed mutants, H105A and D167N, further
supports this conclusion. We show that PplD is a metalloenzyme
with an active site D-H-H triad coordinating a Zn2+ ion. The
enzymatic mechanism involves a Zn2+-coordinated water molecule acting as a nucleophile, and a conserved histidine residue,
H105, acting as a bifunctional acid/base catalyst.
Phylogenetic analysis of PplD homologs in bacterial genomes
suggests the occurrence of GlcN 1-phosphate in the peptidoglycan linkage of the polysaccharides in the majority of
streptococci except for a few members of the S. mitis group that
decorate peptidoglycan with choline-containing WTAs. Thus,
the presence of PplD in bacterial genomes correlates with the
expression of the Rha-containing polysaccharides in these bacteria. Interestingly, the GlcN content of the GAC linkage region
varies considerably in the analyzed streptococcal species, from
very high in the S. equi, S. mutans and GAS strains (about
80–90%) to rather intermediate in GBS A909 (about 30%). Our
analysis of the two GAC isoforms with GlcN and GlcNAc linker
residues indicates that they are chromatographically and compositionally identical, except for N-acetylation of the linkage unit
GlcN. Since GAC is presumably synthesized with GlcNAc
1-phosphate at the reducing terminus and it seems unlikely that
the LCP transferases catalyzing the transfer of the glycan to cell
wall would accept both N-acetyl-containing substrates and those
devoid of this group, N-deacetylation probably occurs after
transfer to cell wall. This conclusion is supported by the observation that GlcNAc 1-phosphate-linked polysaccharides, released
from GAS saccules by mild acid, appear to be primarily localized
to regions of active cell wall synthesis. The simplest explanation
is that the nascent GAC chains have not yet had an opportunity
to interact with PplD.
At this time, it is not clear what primary advantage deacetylation of linkage unit GlcNAc units might confer on individual
streptococci. Introduction of the positive charge into the linkage
unit could conceivably stabilize the phosphodiester linkage.
However, the presence of the primary amine might also present a
vulnerability to hydrolysis by acidiﬁed nitrite. In mammals,
sodium nitrite serves as a source for generation of nitric oxide
(NO), a central biological mediator23. Nitrite is formed via the
enzymatic oxidation of NO in the blood and tissues57, and
reduction of dietary nitrate by anaerobic bacteria colonizing the
oral cavity and gastrointestinal tract58. In the oral cavity, nitrite is
actively concentrated by salivary glands reaching up to 2 mM
after a dietary nitrate load58. The Streptococcus genus dominates
the majority of oral surfaces59. These bacteria produce byproducts of fermentation, lactic and acetic acids, that cause a
signiﬁcant decrease in pH level to 5.5 and below, which is sufﬁcient to release the rhamnopolysaccharides from streptococcal
species by deamination using nitrite. Since oral microbiota affect
many aspects of human health, one may wonder whether streptococci shed the polysaccharides in vivo, and whether the products of hydrolysis, free polysaccharide and unmasked
peptidoglycan, induce host immune responses and contribute to
the complex interplay of oral microbiota.
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In S. iniae, the PplD homolog was previously identiﬁed as a
signiﬁcant virulence factor promoting bacterial infection. The S.
iniae pplD mutant displayed attenuated virulence in the hybrid
striped bass model, decreased survival in whole ﬁsh blood and
increased sensitivity to lysozyme killing43. We demonstrate that
in GAS, PplD and PgdA N-deacetylases promote resistance to
cationic AMPs (lysozyme, hGIIA, and histones). These AMPs
vary from 14 to 21 kDa in size, and attack pathogens by divergent
mechanisms60. hGIIA catalyzes the hydrolysis of bacterial phospholipids including phosphatidylglycerol61–63 and is considered a
major human host-protective factor against Gram-positive
pathogens64–66. Lysozyme catalyzes the hydrolysis of glycosidic
bonds of peptidoglycan. The antimicrobial action of histones has
been attributed to the disruption of membrane integrity67. Furthermore, similar to histones, lysozyme and hGIIA can insert into
negatively charged bacterial membrane forming pores52,68–71.
The decreased resistance of the mutants defective in PplD and
PgdA to the tested AMPs may be explained by a decrease of the
positive charge inside the cell wall. To reach the plasma membrane, AMPs have to traverse the Gram-positive cell envelope.
There is substantial evidence that changes in the net charge of cell
envelope components, peptidoglycan and teichoic acids, modulate the resistance of bacteria to AMPs63,66,72–75. We previously
demonstrated that modiﬁcation of GAC and the S. mutans
rhamnopolysaccharide with negatively charged GroP moieties
renders GAS and S. mutans more sensitive to hGIIA activity15. In
this study, we reveal that the GroP modiﬁcation confers sensitivity of GAS to lysozyme and histone mixture also. Thus, these
data support the conclusion that PplD and PgdA contribute to
protection of bacteria against AMPs by neutralizing a net negative
charge of the cell wall polysaccharides (Fig. 7c).
In sum, the results of this study form a foundation for the
design of signiﬁcantly improved GAS glycoconjugate vaccine
based on GAC and provide insight into the function of cell wall
modiﬁcations in protection of bacteria against cationic AMPs.
Methods
Bacterial strains, growth conditions, and media. All plasmids, strains and primers used in this study are listed in Supplementary Tables 5 and 6. Streptococcal
strains were grown in BD Bacto Todd-Hewitt broth supplemented with 1% yeast
extract (THY) without aeration at 37 °C. S. mutans strains were grown on THY
agar at 37 °C with 5% CO2. E. coli strains were grown in Lysogeny Broth (LB)
medium or on LB agar plates at 37 °C. When required, antibiotics were included at
the following concentrations: ampicillin and streptomycin at 100 µg mL−1 for E.
coli; erythromycin at 500 µg mL−1 for E. coli and 5 µg mL−1 for streptococci;
chloramphenicol at 10 µg mL−1 for E. coli and 2 µg mL−1 for streptococci; spectinomycin at 200 µg mL−1 for E. coli and 200 µg mL−1 for streptococci; kanamycin
at 50 µg mL−1 for E. coli and 300 µg mL−1 for streptococci.
Construction of mutant strains. For construction of the GAS, GBS and S. mutans
deletion mutants, GAS NZ131, GBS A909, and S. mutans Xc chromosomal DNA,
respectively, were used as the templates for ampliﬁcation of DNA fragments
encompassing the upstream and downstream regions ﬂanking the gene of interest.
The primers used to generate the deletion mutants are listed in Supplementary
Table 6. To construct GASΔpplD, the DNA fragments were ampliﬁed using two
primers pairs JC480/JC481 and JC482/JC483, digested with the restriction enzymes
and cloned into pFED76076. The antibiotic resistance cassette for kanamycin
(aph3A), ampliﬁed from pOskar77 using two primers pairs JC292/JC304, was
cloned between the upstream and downstream fragments to generate the plasmid
pJC344-kan for selective allelic replacement. The plasmid was electroporated into
the GAS NZ131 cells.
To construct GASΔpplDΔpgdA, two DNA fragments were ampliﬁed using two
primers pairs PplD-BglII-F/PplD-SalI-R and PplD-BamH-F/PplD-XhoI-R
(Supplementary Table 2), digested with BglII/SalI and ligated into BglII/SalIdigested pUC19BXspec13. The resultant plasmid was digested with BamHI/XhoI,
and used for ligation with the second PCR product that was digested with BamHI/
XhoI. The resultant plasmid, pUC19BXspec-pplD, was digested with BglII and
XhoI to obtain a DNA fragment containing a nonpolar spectinomycin resistance
cassette ﬂanked with the pplD upstream and downstream regions. This DNA
fragment was cloned into BglII/XhoI-digested pHY304 to generate pHY304ΔpplDNZ131. The resultant plasmid was electroporated into the GASΔpgdA78
12

To construct GASΔgacH, GBSΔpplD, and SMUΔpplD, we used a PCR
overlapping mutagenesis approach, as previously described15. Brieﬂy, 600-700 bp
fragments both upstream and downstream of the gene of interest were ampliﬁed
with designed primers that contained 16-20 bp extensions complementary to the
nonpolar antibiotic resistance cassette (Supplementary Table 6). The nonpolar
spectinomycin and chloramphenicol resistance cassettes were PCR-ampliﬁed from
pLR16T and pDC123, (Supplementary Table 5), respectively, and used for
mutagenesis of pplD and gacH, respectively. Two fragments ﬂanking the gene of
interest and the antibiotic resistance cassette were puriﬁed using the QIAquick
PCR puriﬁcation kit (Qiagen) and fused by Gibson Assembly (SGA-DNA). A PCR
was then performed on the Gibson Assembly sample using primers listed in
(Supplementary Table 6) to amplify the fused fragments. The assembled DNA
fragment for mutagenesis of S. mutans pplD was directly transformed into the S.
mutans Xc cells by electroporation. The transformants were selected on THY agar
containing spectinomycin.
The assembled DNA fragments for mutagenesis of GAS gacH and GBS pplD
were cloned into pHY304 by the use of restriction enzymes to generate the
plasmids pHY304ΔgacH-NZ131 and pHY304ΔpplD-GBS, respectively. The
plasmids were electroporated into the GAS NZ131 and GBS A909 cells to obtain
GASΔgacH and GBSΔpplD, respectively.
A two-step temperature-dependent selection process was used to isolate the
desired GAS and GBS mutants15. The transformants were selected on THY agar
containing the corresponding antibiotic and screened for sensitivity to
erythromycin. Single colonies sensitive to erythromycin were picked. Doublecrossover recombination was conﬁrmed by PCR and Sanger sequencing using the
primers listed in Supplementary Table 6.
For complementation of GASΔpplD, GASΔpplDΔpgdA, and SMUΔpplD, a
promoterless pplD gene was ampliﬁed from GAS NZ131 using the primers listed in
Supplementary Table 6. The PCR product was ligated into pDC123 vector, yielding
ppplD. To make a catalytically inactive variant of pplD, the mutations H105A and
D167N were introduced into ppplD using Gibson Assembly site-directed
mutagenesis (SGI-DNA) with the primers listed in Supplementary Table 6, yielding
the ppplD-H105A, ppplD-D167N, and ppplD-H105A/D167N plasmids. The
plasmids were transformed into GASΔpplD, GASΔpplDΔpgdA, and SMUΔpplD.
Chloramphenicol resistant single colonies were picked and checked for presence of
ppplD by PCR and Sanger sequencing. Complementation of GASΔgacH with WT
gacH and gacH-T530A on pDCerm expression plasmid was conducted as
previously described15.
Construction of the plasmids for expression of ePplD and GFP-AtlAEfs. To
create a vector for expression of the extracellular domain of PplD (ePplD), the gene
was ampliﬁed from GAS 5005 chromosomal DNA using the primer pair pplDNcoI-f and pplD-XhoI-r. The PCR product was digested with NcoI and XhoI, and
ligated into NcoI/XhoI-digested pCDF-NT vector. The resultant plasmid, pCDFPplD, encodes pplD fused at the N-terminus with a His-tag followed by a TEV
protease recognition site. To construct a vector for expression of GFP-AtlAEfs
(pKV1644), 5′ fragment encoding GFP was PCR-ampliﬁed from pHR-scFv-GCN4sfGFP-GB1-NLS-dWPRE using primer pairs sfGFP_BspH and gfp-0799-R, and 3′
fragment encoding a C-terminal cell wall-binding domain of AtlA was ampliﬁed
from E. faecalis V583 DNA using the primer pair gfp-0799-F and 0799-Hind. GFP
fusion was constructed using a PCR overlapping mutagenesis approach, digested
with BspHI/HindIII and ligated into NcoI/HindIII-digested pRSF-NT vector.
Crystallization and structure determination of ePplD. E. coli Rosetta (DE3) cells
carrying pCDF-PplD were grown to an OD600 of 0.6 and induced with 0.25 mM
isopropyl β-D-1-thiogalactopyranoside (IPTG) at 18 °C for approximately 16 h.
The cells were lysed in 20 mM Tris-HCl pH 7.5, 300 mM NaCl using a microﬂuidizer cell disrupter. The soluble fractions were puriﬁed by Ni-NTA chromatography as previously reported for GacH15. The eluate was dialyzed into 20 mM
Tris-HCl pH 7.5, 300 mM NaCl in the presence of TEV protease (1 mg per 20 mg
of protein). The dialyzed sample was reapplied to a Ni-NTA column equilibrated in
20 mM Tris-HCl pH 7.5, 300 mM NaCl. ePplD was further puriﬁed by size
exclusion chromatography on a Superdex 200 column in 20 mM HEPES pH 7.5,
100 mM NaCl. Fractions collected during elution from the column were analyzed
for purity by SDS-PAGE (Supplementary Fig. 11) and concentrated to 4.7 mg/mL.
Initial screening for crystallization conditions was performed using MCSG I-IV
crystallization screens (Anatrace). The optimized crystals were obtained using the
vapor diffusion method in 20% PEG3350, 0.2 M zinc acetate, 0.1 M imidazole, pH
8.0. Crystals were transferred to crystallization solution supplemented with 20%
glycerol and vitriﬁed in liquid nitrogen prior to data collection. Due to the presence
of Zn2+ ions in the crystallization solution, the data were collected above Zn
anomalous scattering edge at wavelength 1.27 Å at beamline BL9-2 at the Stanford
Synchrotron Radiation Laboratory (SSRL) using Blu-Ice 5. The data were processed
and scaled using XDS and XSCALE79. The structure was solved by singlewavelength anomalous diffraction phasing using an automated Phaser SAD
pipeline80. The initial zinc positions were found using SHELXD81. Following
density modiﬁcation with Parrot, the initial model was built using Buccaneer82,83.
The model was improved using manual rebuilding in Coot alternating with
reﬁnement by phenix.reﬁne84,85. The ﬁnal model had 96% of residues in the
favorable region of the Ramachandran plot and 4% in additionally allowed region.
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Lysozyme, hGIIA, and histone susceptibility assay. Frozen stocks of GAS variants were used for microbial susceptibility tests with hGIIA, histone mixture from
calf thymus (Millipore Sigma, 10223565001) and lysozyme from egg white (Millipore Sigma, L6876). Recombinant hGIIA was produced as described previously86.
To make frozen aliquots, GAS strains, cultured overnight in THY medium, were
diluted 1:100 into fresh THY medium and allowed to grow to mid-logarithmic
phase (OD600 = 0.5). Bacteria were collected by centrifugation, washed twice with
PBS and re-suspended in HEPES buffer solution (20 mM HEPES pH 7.5, 2 mM
CaCl2 and 1% BSA) with 15% glycerol. The aliquots were frozen and stored at
−80 °C until used in viability assays. Aliquots were thawed and diluted to 1:1000 in
HEPES buffer solution. The susceptibility experiments were performed as described previously75. Brieﬂy, the AMP (hGIIA, lysozyme, and histone mixture) was
serially diluted in HEPES solution. Diluted bacterial cultures (10 µl) were mixed
with the AMP (10 µl) in a conical 96-well plate. The plate was incubated at 37 °C
with 5% CO2 for 2 h. After incubation, the bacterial suspensions were diluted with
200 µl PBS and 40 µl was plated on THY agar plates (10 cm) for quantiﬁcation.
After overnight incubation, the CFU were counted. Survival rate was calculated as
Survival (% of inoculum) = (counted CFU * 100)/CFU count of original (no AMP
added sample). Drop test assay with varying concentrations of lysozyme was
conducted as previously described for zinc concentrations15.

and reserved for further analysis for rhamnose content or used for ﬂuorescent
microscopy.

Muramidase activity of lysozyme on GAS. Overnight cultures of the GAS strains
were diluted (1:100) into fresh THY broth and grown to an OD600 of 0.5. Cell
suspension (10 mL) was centrifuged (3200 × g, 10 min) and resuspended with
either 1 mg mL−1 lysozyme or 62.5 U/ml mutanolysin (Sigma, M9901) or no
enzyme (negative control) in sterile PBS (10 mL). After 0 and 18 h of incubation at
37 °C, 0.2 mL was centrifuged (16,000 × g, 3 min). The supernatant was transferred
to a fresh centrifuge tube and concentrated to 30 µl ﬁnal volume using SpeedVac
vacuum concentrator. Supernatant (5 µl) was spotted on a nitrocellulose membrane. The membrane was blocked for 1 h with 7% skim milk in PBS/0.1% Tween
20 and incubated with an anti-GAC antibody diluted 1:5000 (Abcam, ab9191).
Bound antibodies were detected with a peroxidase-conjugated goat anti-rabbit IgG
antibody and the Amersham Bioscience ECL (enhanced chemiluminescence)
western blotting system. ImageJ software was used to quantify the signal of polysaccharides released.

Phosphate assays. During GAC puriﬁcation, total phosphate content was
determined by the malachite green method following digestion with perchloric
acid. Fractions containing 10–80 µL were heated to 110 °C with 40 µL 70% perchloric acid (Fisher Scientiﬁc) in 13 × 100 borosilicate disposable culture tubes for
1 h. The reactions were diluted to 160 µL with water and 100 µL was transferred to
a ﬂat-bottom 96-well culture plate. Malachite Green reagent (0.2 mL) was added
and the absorbance at 620 nm was read after 10 min at room temperature. Malachite Green reagent contained 1 vol 4.2% ammonium molybdate tetrahydrate (by
weight) in 4 M HCl, 3 vol 0.045% malachite green (by weight) in water and 0.01%
Tween 20. Phosphate concentrations were estimated using phosphate
standard curve.

Isolation of cell wall and sacculi. Cell wall was isolated from exponential phase
cultures by the SDS-boiling procedure as described for S. pneumoniae87. Puriﬁed
cell wall samples were lyophilized and stored at −20 °C before the analysis. S.
mutans and GAS sacculi were obtained by the SDS-boiling procedure followed by 2
washes with 1 M NaCl and 5 washes with water as outlined25. To analyze sensitivity
of GAC cleavage to chemical treatments, the GAS sacculi were additionally treated
with 5 mg mL−1 trypsin (Sigma, T-8253) at 37 °C overnight, sedimented
(32,000 × g for 15 min), and washed 4 times by resuspension in water. This
treatment removes binding of the GAS sacculi to the microcentrifuge plastic tubes.
Sacculi were resuspended in water and stored at 4 °C before the analysis.
HONO deamination. Polysaccharide was released from sacculi or highly enriched
cell wall preparations by HONO deamination essentially as described22 with minor
modiﬁcation. Brieﬂy, reactions contained sacculi (OD600 = 3.4) or isolated cell
walls (2–5 mg mL−1), in 0.2 N Na Acetate pH 4.5 and 1.5 M NaNO2 (added in
three equal portions over a period of 90 min) at room temperature. Following
deamination, the reaction was stopped by the addition of one equivalent of ethanolamine and centrifuged (60,000 × g, 10 min). The supernatant was removed and
transferred to an Amicon Ultra-0.5 mL (3000 MWCO) spin ﬁlter. The pellet was
washed two times by resuspension in water (1/2 of the original reaction volume),
re-sedimented, and the washings were combined with the initial supernatant. The
washed pellet was re-suspended in water and reserved for analysis, or discarded.
The released material was desalted by several sequential cycles of dilution with
water and re-concentration on the spin ﬁlter, recovered in a convenient volume of
water and either reserved for analysis or puriﬁed further by chromatography on Bio
Gel P150 and ion exchange on DEAE-Toyopearl.
Mild acid hydrolysis. Mild acid hydrolysis was performed, either with or without
prior N-acetylation, as previously described for WTA of L. plantarum20 with some
modiﬁcations. Chemical N-acetylation reactions contained sacculi (OD600 = 3.4) or
isolated cell walls (2–5 mg/ml), resuspended in 1 mL of saturated NaHCO3, and 2%
acetic anhydride. After 1 h on ice, the reactions were allowed to warm to room
temperature overnight. After incubation at room temperature overnight, the
reactions were diluted with 2 volumes of water and sedimented (50,000 × g,
10 min). The insoluble residue was washed three times by resuspension with 3 mL
water followed by sedimentation (50,000 × g, 10 min). For mild acid hydrolysis,
sacculi or cell wall material was re-suspended in 0.02 N HCl and heated to 100 °C
for 20 min. The reactions were cooled on ice, neutralized by the addition of 1 N
NaOH (1 equivalent) and sedimented (50,000 × g, 10 min). The supernatant fraction was removed and reserved, and the pellet was re-suspended in water and resedimented. The supernatant fractions were combined and either analyzed or
puriﬁed further. The pellet fractions were resuspended in an equal volume of water

Fluorescent and differential interference contrast (DIC) microscopy. GAS
sacculi obtained by the SDS-boiling procedure were subjected to mild acid
hydrolysis or deamination with HONO as outlined above. Untreated or treated
sacculi were resuspended in PBS to an OD600 = 0.3, and incubated with 19.8 µg mL
−1 GFP-AtlAEfs for 30 min at room temperature. The samples were washed three
times with water, dried at room temperature, and mounted on a microscope slide
with ProLong Glass Antifade (Invitrogen). Samples were imaged on a Leica SP8
equipped with 100X, 1.44 N.A. objective and DIC optics.
Chromatography of GAC. GAC, released by either deamination with HONO or by
mild acid treatment, was partially puriﬁed by size-exclusion chromatography (SEC)
on a 1 × 18 cm column Bio Rad BioGel P150 equilibrated in 0.2 N Na acetate, pH
3.7, 0.15 M NaCl. Following SEC, GAC was further fractionated by ion-exchange
chromatography on a 1 × 18 cm column of DEAE-Toyopearl (TosoHaas) equilibrated in 10 mM HEPES, pH 8. After elution with two column volumes, DEAEbound glycans were eluted with an 80 mL gradient (0–0.5 M) of NaCl.

Modiﬁed anthrone assay. Total Rha content was estimated using a minor
modiﬁcation of the anthrone procedure. Reactions contained 0.08 mL of aqueous
sample and water and 0.32 mL anthrone reagent (0.2% anthrone in concentrated
H2SO4). The samples were heated to 100 °C, 10 min, cooled in water (room temperature), and the absorbance at 580 nm was recorded. Rha concentrations were
estimated using L-Rha standard curve.
Analysis of glycosyl composition by gas chromatography-mass spectrometry
(GC-MS). Saccharide compositions were determined as either trimethylsilyl (TMS)
derivatives of O-methyl glycosides, following methanolysis or as alditol acetates
following hydrolysis with 2 N TFA and peracetylation, as described below88.
Methanolic HCl (1 N) was prepared by the careful dilution of the required amount
of acetyl chloride into rapidly stirred, anhydrous methanol at 0 °C. TMS-methyl
glycoside samples contained 10 nmole inositol as internal standard and were dried
thoroughly from absolute ethanol (3 times), under dry nitrogen gas in glass
13 × 100 screw cap tubes with teﬂon-lined caps. Dried samples were dissolved in
0.2 mL 1 N methanolic HCl and heated to 100 °C, 3 h. Following methanolysis,
samples were neutralized with 5-10 mg AgCO3 and re-N-acetylated with 0.1 mL
acetic anhydride overnight. Re-N-acetylated methyl glycosides were recovered from
the solid residue in 1 mL of methanol, dried thoroughly with toluene 2 times, to
azeotrope the acetic anhydride, and trimethysilylated with 25 µL TMS-HT (TCI
America) at 80 °C, 30 min. TMS-methyl glycosides were dried brieﬂy with addition
of toluene under dry nitrogen gas, redissolved in 0.1 mL hexane and analyzed by
gas chromatography/chemical ionization (methane) mass spectrometry on a
Thermo Scientiﬁc Trace 1310 gas chromatograph, 0.25 mm × 15 m DB-1701 (J&W
Scientiﬁc) capillary column, and an ISQ LT single quadrupole mass spectrometer
in selective ionization mode (SIM) monitoring appropriate speciﬁc high molecular
ions. Ion source temperature was 200 °C and transfer line temperature was 240 °C.
Samples (1 µL) were injected in split mode (split ﬂow 8 mL/min, split ratio 16:1)
and chromatographed with He carrier gas (0.5 mL/min) with a temperature program of 100 °C for 1 min, and 10 °C/min to 280 °C with a ﬁnal time of 2 min and
detected in positive ion mode. The unknown TMS-sugars co-chromatographed
with derivatives of authentic sugar standards and their respective full scan mass
spectra contained [MH]+, [MH-16]+, [MH-32]+, [MH-90]+, [MH-122]+ and
[MH-180]+ as the only high molecular weight ions. Speciﬁc ions for selective ion
monitoring were: TMS3-O-methyl-rhamnose (M/Z = 363 [MH-32]+), TMS4-Omethyl-glucose (M/Z = 361 [MH-122]+), TMS6-inositol (M/Z = 433 [MH-180]+)
and TMS3-O-methyl-GlcNAc (M/Z = 420 [MH-32]+).
Sodium borohydride-reduced, intact mild acid- or HONO-released
polysaccharides, were fractionated by SEC on BioGel P150 and ion-exchange
chromatography on DEAE-Toyopearl, and analyzed for reducing end sugars as
alditol acetates. Polysaccharides were concentrated and desalted over Amicon
Ultra-0.5, 3000 Da cut-off, centrifugal ﬁlters, supplemented with 1 nmol
mannitol internal standard and hydrolyzed in 2 N TFA, 120 °C, 1 h. Samples
were dried under air with addition of 1-propanol 3 times and peracetylated with
0.2 mL pyridine/acetic anhydride (1:1), 100 °C, 30 min. Samples were diluted
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with 2 mL CHCl3, partitioned with 2 mL water 3 times and dried under a stream
of dry nitrogen gas with addition of toluene at room temperature. Alditol acetate
analysis was carried out as described above for TMS-methyl glycosides except
that the temperature program was 120 °C, 1 min, and 5 °C per minute to 250 °C,
with a ﬁnal time of 2.5 min. Full scan spectra of the alditol acetates contained
[MH-60]+ as the only high molecular weight ion detected. Chromatograms were
prepared by selected ion monitoring using: Ac4-2,5-anhydromannitol (M/
Z = 273 [MH-60]+), Ac6-mannitol (M/Z = 375 [MH-60]+) and Ac6-GlcNAcitol
(M/Z = 374 [MH-60]+).
Quantities of component sugars were calculated from GC areas after
normalization to the internal standard and response factor corrections. Response
factors were calculated from standard mixtures of sugars and internal standard
using the formula: Rf = (Ax/Ais)/(Cx/Cis) in which, Ax is GC area of analyte, Ais is
GC area of internal standard, Cx is amount of analyte and Cis is amount of internal
standard. Amounts of sugars were calculated using the formula: Cx = Cis × (Ax/
Ais)/Rf. In this analysis, an exponential increase in response factor associated with
increasing amounts of analyte relative to internal standard was observed. To
correct for this change in response factor, standard curves of increasing amounts of
analytes to a constant quantity of internal standard were prepared and used to
estimate the appropriate response factor.
NMR spectroscopy. Cell wall isolated from GAS 5005 was used for puriﬁcation of
GAC for NMR analysis15. NMR experiments on the GAC polysaccharide, ~7 mg
in D2O (99.96%) pD ~8, were acquired at 323.2 K unless otherwise stated using
the following Bruker spectrometers: AVANCE III 700 MHz equipped with a 5 mm
TCI Z-Gradient Cryoprobe (1H/13C/15N), AVANCE III 600 MHz equipped with a
5 mm TXI inverse Z-Gradient probe (1H/31P/13C), Avance III HD 800 MHz
equipped with a 3 mm TCI cryoprobe and an Avance III HD 600 MHz equipped
with a 5 mm BBI probe. Chemical shifts are reported in ppm using internal
sodium 3-trimethylsilyl-(2,2,3,3-2H4)-propanoate (TSP, δH 0.00 ppm), external
1,4-dioxane in D2O (δC 67.40 ppm) and 2% H3PO4 in D2O (δP 0.00 ppm) as
references.
1H,1H-TOCSY NMR experiments were recorded with mixing times of 10, 30,
60, 90, and 120 ms. 1H,1H-NOESY experiments89 were collected with mixing
times of 100 and 200 ms at 700 MHz and at 800 MHz. Multiplicity-edited
1H,13C-HSQC experiments90 were carried out with an echo/antiecho-TPPI
gradient selection with and without decoupling during the acquisition. 1H,13CHSQC-TOCSY experiments were acquired using the MLEV17 sequence for
homonuclear Hartman-Hahn mixing with durations of 20, 40, 80, and 120 ms, an
echo/antiecho-TPPI gradient selection and heteronuclear decoupling during
acquisition. The 1H,13C-HMBC experiment with a three-fold low-pass J-ﬁlter to
suppress one-bond correlations and a band-selective 1H,13C-CT-HMBC were run
with a nominal long-range J value of 8 Hz. 1H,31P-Hetero-TOCSY experiments27
were collected using a DIPSI2 sequence with mixing times of 50 and 80 ms.
1H,31P-HMBC experiments were recorded using an echo/antiecho gradient
selection using 25, 50, and 90 ms delays for J evolution, 8k and 512 points in the F2
and F1 dimensions, respectively, a nominal value for long-range nJCH of 8 Hz. The
3D 1H,13C,31P91 spectra were obtained using echo/anti-echo gradient selection
and constant time in t2 with a nominal value of nJCP of 5 Hz and without
multiplicity selection.
Non-uniform sampling (NUS) was employed for sparse sampling of 2D NMR
experiments with a 50% or 25% coverage, thereby facilitating an increase in the
number of increments in the indirect dimension by a factor of 2 or 4, respectively,
with overall equal measurement time. The Multi-Dimensional Decomposition
(MDD-NMR)92–94 algorithm was employed to reconstruct the FIDs. The spectra
were acquired using TopSpin 3.1 software (Bruker BioSpin) for the 600 MHz
spectrometer and TopSpin 3.2 (Bruker BioSpin) for the 700 MHz spectrometer.
Additional NMR spectra acquired at the Swedish NMR Centre used TopSpin 3.5
pl7 software (Bruker BioSpin) for the 600 MHz spectrometer and TopSpin 3.6.2
(Bruker BioSpin) for the 800 MHz spectrometer. The spectra were processed and
analyzed using TopSpin 4.0.1 software (Bruker BioSpin).
Statistical analysis. Unless otherwise indicated, statistical analysis was carried out
on pooled data from at least three independent biological repeats. Statistical analyses were performed using Graph Pad Prism version 9.2.0. Quantitative data were
analyzed using either one-way or two-way ANOVA with either Tukey’s or Bonferroni multiple comparison test. Symbols and error bars represent the mean and
S.D., respectively. A p-value equal to or less than 0.05 was considered statistically
signiﬁcant.
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